Related references
Note: Only part of the references are listed.The Role of Inflammation in Depression and Fatigue
Chieh-Hsin Lee et al.
FRONTIERS IN IMMUNOLOGY (2019)
Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis
S. P. Leighton et al.
MOLECULAR PSYCHIATRY (2018)
The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Sahar Mohamed El-Haggar et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
Jia Huang et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C. A. Kohler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
Janus Christian Jakobsen et al.
BMC PSYCHIATRY (2017)
Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
Jennifer L. Remus et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
A meta-analysis of chemokines in major depression
Harris A. Eyre et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review
Ke Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Atefeh Zeinoddini et al.
DEPRESSION AND ANXIETY (2015)
Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression
Maha A. E. Ahmed et al.
HORMONES AND BEHAVIOR (2015)
Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis
T. Kreisel et al.
MOLECULAR PSYCHIATRY (2014)
Lipopolysaccharide repeated challenge followed by chronic mild stress protocol introduces a combined model of depression in rats: Reversibility by imipramine and pentoxifylline
Al-Shaimaa A. Elgarf et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors
David Baumeister et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2014)
INFLAMMATORY CYTOKINES IN DEPRESSION: NEUROBIOLOGICAL MECHANISMS AND THERAPEUTIC IMPLICATIONS
J. C. Felger et al.
NEUROSCIENCE (2013)
Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression
Ladan Kashani et al.
PSYCHONEUROENDOCRINOLOGY (2013)
A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting
Waguih William IsHak et al.
QUALITY OF LIFE RESEARCH (2013)
A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia
Ross J. Tynan et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
Seyed-Hesameddin Abbasi et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: Involvement in depression
Zili You et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Pretreatment with pentoxifylline has antidepressant-like effects in a rat model of acute myocardial infarction
Thierno Madjou Bah et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression
Stefan M. Gold et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression
R. C. Shelton et al.
MOLECULAR PSYCHIATRY (2011)
Association Between Depression and Inflammation-Differences by Race and Sex: The META-Health Study
Alanna Amyre Morris et al.
PSYCHOSOMATIC MEDICINE (2011)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Protection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain
Akram Ranjbar et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2010)
CLINICAL TRIAL OF ADJUNCTIVE CELECOXIB TREATMENT IN PATIENTS WITH MAJOR DEPRESSION: A DOUBLE BLIND AND PLACEBO CONTROLLED TRIAL
Shahin Akhondzadeh et al.
DEPRESSION AND ANXIETY (2009)
IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Ja Wook Koo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial
Shahrokh Amiri et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression
I. Goshen et al.
MOLECULAR PSYCHIATRY (2008)
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study
Julien Mendlewicz et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)
Quality-of-life impairment in depressive and anxiety disorders
MH Rapaport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Depression and quality of life: Results of a follow-up study
MC Angermeyer et al.
INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY (2002)
Treatment of depression is associated with suppression of nonspecific and antigen-specific TH1 responses in multiple sclerosis
DC Mohr et al.
ARCHIVES OF NEUROLOGY (2001)
Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal
S Akhondzadeh et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2000)
Share Paper
